Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Teradata Corp
TDC
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Dorian LPG
LPG
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||
Cash flow from continuing operating activities | 93.79%-1.19M | -2,059.86%-19.19M | -80.05%979.16K | -1.70%4.91M | 4.99M |
Net income from continuing operations | -58.52%-29.59M | -239.90%-18.67M | -74.77%-5.49M | -5,330.38%-3.14M | --60.08K |
Operating gains losses | 758.12%208.09K | 446.42%24.25K | 1,129.70%4.44K | 98.43%-431 | ---27.5K |
Depreciation and amortization | -12.34%5.24M | 18.85%5.98M | -0.03%5.03M | -4.84%5.03M | --5.29M |
Deferred tax | 258.44%434.32K | 116.53%121.17K | -2,331.95%-732.87K | -154.25%-30.14K | --55.55K |
Other non cash items | -39.68%653.46K | 19.16%1.08M | 39.75%909.09K | 28.27%650.49K | --507.12K |
Change In working capital | 100.54%74.99K | -1,390.72%-13.78M | 85.65%1.07M | 165.85%574.99K | ---873.11K |
-Change in receivables | 99.47%-79.87K | -3,731.96%-15.04M | -49.25%414.05K | 808.13%815.92K | ---115.22K |
-Change in inventory | 126.34%757.52K | -197.16%-2.88M | -99.69%-967.99K | ---484.75K | --0 |
-Change in payables and accrued expense | -108.98%-347.37K | 583.94%3.87M | -431.92%-798.9K | 129.08%240.69K | ---827.78K |
-Change in other current assets | 93.62%-30.84K | -371.85%-483.36K | -38.00%177.8K | 488.50%286.76K | ---73.81K |
-Change in other current liabilities | -127.35%-258.98K | -51.30%947.02K | 390.21%1.94M | -276.89%-670.07K | ---177.79K |
-Change in other working capital | 117.83%34.53K | -165.00%-193.64K | -22.91%297.91K | 20.20%386.43K | --321.49K |
Cash from discontinued investing activities | |||||
Operating cash flow | 93.79%-1.19M | -2,059.86%-19.19M | -80.05%979.16K | -1.70%4.91M | --4.99M |
Investing cash flow | |||||
Cash flow from continuing investing activities | 77.40%-2.13M | -80.03%-9.41M | -264.96%-5.22M | -217.05%-1.43M | -451.51K |
Net PPE purchase and sale | 52.08%-2.11M | 16.01%-4.4M | -272.58%-5.24M | -247.52%-1.41M | ---404.35K |
Net intangibles purchase and sale | 99.43%-18.48K | -24,399.71%-3.24M | 49.71%-13.24K | 44.20%-26.32K | ---47.16K |
Net business purchase and sale | --0 | -7,374.40%-1.77M | --24.28K | --0 | --0 |
Cash from discontinued investing activities | |||||
Investing cash flow | 77.40%-2.13M | -80.03%-9.41M | -264.96%-5.22M | -217.05%-1.43M | ---451.51K |
Financing cash flow | |||||
Cash flow from continuing financing activities | -18.22%17.12M | 96.54%20.94M | 1,040.30%10.65M | 34.47%-1.13M | -1.73M |
Net issuance payments of debt | -73.39%-4.2M | 6.48%-2.42M | -128.69%-2.59M | 22.87%-1.13M | ---1.47M |
Net common stock issuance | 2.56%20.87M | 53.62%20.35M | --13.24M | --0 | --0 |
Cash dividends paid | ---- | ---- | ---- | ---- | --0 |
Proceeds from stock option exercised by employees | -83.19%506.69K | --3.01M | --0 | --0 | ---- |
Net other financing activities | ---49.66K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | |||||
Financing cash flow | -18.22%17.12M | 96.54%20.94M | 1,040.30%10.65M | 34.47%-1.13M | ---1.73M |
Net cash flow | |||||
Beginning cash position | -48.08%8.23M | 56.50%15.85M | 31.77%10.13M | 40.76%7.69M | --5.46M |
Current changes in cash | 280.28%13.81M | -219.50%-7.66M | 173.49%6.41M | -16.68%2.34M | --2.81M |
Effect of exchange rate changes | -281.28%-62.93K | 105.07%34.71K | -789.95%-684.14K | 116.92%99.16K | ---585.92K |
End cash Position | 166.97%21.97M | -48.08%8.23M | 56.50%15.85M | 31.77%10.13M | --7.69M |
Free cash flow | 87.64%-3.32M | -528.52%-26.84M | -222.83%-4.27M | -22.96%3.48M | --4.51M |
Currency Unit | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | -- |